Availability: From financialisation to innovation in UK big pharma

From financialisation to innovation in UK big pharma: AstraZeneca and GlaxoSmithKline

Saved in:

Bibliographic Details
Main Authors:	Tulum, Öner ca. 20./21. Jh (Author), Andreoni, Antonio (Author), Lazonick, William (Author)
Format:	Electronic eBook
Language:	English
Published:	Cambridge, United Kingdom Cambridge University Press 2022
Series:	Cambridge elements. Elements in reinventing capitalism
Subjects:	AstraZeneca (Firm) / Finance GlaxoSmithKline / Finance Pharmaceutical industry / Finance / Great Britain Biotechnology industry / Finance / Great Britain
Links:	https://doi.org/10.1017/9781009278140 https://directory.doabooks.org/handle/20.500.12854/142969
Physical Description:	1 Online-Ressource (104 Seiten) Diagramme
ISBN:	9781009278140
DOI:	10.1017/9781009278140

Staff View

MARC


LEADER	00000nam a22000001c 4500
001	BV048652297
003	DE-604
005	20240917
007	cr\|uuu---uuuuu
008	230116s2022 xx \|\|\|\| o\|\|\|\| 00\|\|\| eng d
020			\|a 9781009278140 \|c Online \|9 978-1-009-27814-0
024	7		\|a 10.1017/9781009278140 \|2 doi
024	7		\|a 20.500.12854/142969 \|2 hdl
035			\|a (ZDB-20-CBO)CR9781009278140
035			\|a (OCoLC)1362877374
035			\|a (DE-599)BVBBV048652297
040			\|a DE-604 \|b ger \|e rda
041	0		\|a eng
049			\|a DE-12 \|a DE-210 \|a DE-521 \|a DE-1102 \|a DE-1046 \|a DE-1028 \|a DE-1050 \|a DE-573 \|a DE-M347 \|a DE-92 \|a DE-1051 \|a DE-898 \|a DE-859 \|a DE-860 \|a DE-1049 \|a DE-861 \|a DE-863 \|a DE-862 \|a DE-Re13 \|a DE-Y3 \|a DE-255 \|a DE-Y7 \|a DE-Y2 \|a DE-70 \|a DE-2174 \|a DE-127 \|a DE-22 \|a DE-155 \|a DE-91 \|a DE-384 \|a DE-473 \|a DE-19 \|a DE-355 \|a DE-703 \|a DE-20 \|a DE-706 \|a DE-824 \|a DE-945 \|a DE-29 \|a DE-739
100	1		\|a Tulum, Öner \|d ca. 20./21. Jh. \|e Verfasser \|0 (DE-588)1279010541 \|4 aut
245	1	0	\|a From financialisation to innovation in UK big pharma \|b AstraZeneca and GlaxoSmithKline \|c Öner Tulum (The Academic-Industry Research Network), Antonio Andreoni (SOAS University of London), William Lazonick (The Academic-Industry Research Network)
264		1	\|a Cambridge, United Kingdom \|b Cambridge University Press \|c 2022
300			\|a 1 Online-Ressource (104 Seiten) \|b Diagramme
336			\|b txt \|2 rdacontent
337			\|b c \|2 rdamedia
338			\|b cr \|2 rdacarrier
490	0		\|a Cambridge elements. Elements in reinventing capitalism
653		2	\|a AstraZeneca (Firm) / Finance
653		2	\|a GlaxoSmithKline / Finance
653		0	\|a Pharmaceutical industry / Finance / Great Britain
653		0	\|a Biotechnology industry / Finance / Great Britain
700	1		\|a Andreoni, Antonio \|e Verfasser \|0 (DE-588)1019224118 \|4 aut
700	1		\|a Lazonick, William \|e Verfasser \|0 (DE-588)17006090X \|4 aut
776	0	8	\|i Erscheint auch als \|n Druck-Ausgabe, Paperback \|z 978-1-009-27816-4
856	4	0	\|u https://doi.org/10.1017/9781009278140 \|x Verlag \|z kostenfrei \|3 Volltext
856	4	0	\|u https://directory.doabooks.org/handle/20.500.12854/142969 \|x Verlag \|z kostenfrei \|3 Volltext
912			\|a ZDB-20-CBO
912			\|a ZDB-20-CUOA
912			\|a ZDB-94-OAB
943	1		\|a oai:aleph.bib-bvb.de:BVB01-034027060

Record in the Search Index

DE-BY-TUM_katkey	2813030
_version_	1822177014595977216
adam_text
any_adam_object
author	Tulum, Öner ca. 20./21. Jh Andreoni, Antonio Lazonick, William
author_GND	(DE-588)1279010541 (DE-588)1019224118 (DE-588)17006090X
author_facet	Tulum, Öner ca. 20./21. Jh Andreoni, Antonio Lazonick, William
author_role	aut aut aut
author_sort	Tulum, Öner ca. 20./21. Jh
author_variant	ö t öt a a aa w l wl
building	Verbundindex
bvnumber	BV048652297
collection	ZDB-20-CBO ZDB-20-CUOA ZDB-94-OAB
ctrlnum	(ZDB-20-CBO)CR9781009278140 (OCoLC)1362877374 (DE-599)BVBBV048652297
doi_str_mv	10.1017/9781009278140
format	Electronic eBook
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a22000001c 4500</leader><controlfield tag="001">BV048652297</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240917</controlfield><controlfield tag="007">cr\|uuu---uuuuu</controlfield><controlfield tag="008">230116s2022 xx \|\|\|\| o\|\|\|\| 00\|\|\| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781009278140</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-009-27814-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1017/9781009278140</subfield><subfield code="2">doi</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">20.500.12854/142969</subfield><subfield code="2">hdl</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-20-CBO)CR9781009278140</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1362877374</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048652297</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-210</subfield><subfield code="a">DE-521</subfield><subfield code="a">DE-1102</subfield><subfield code="a">DE-1046</subfield><subfield code="a">DE-1028</subfield><subfield code="a">DE-1050</subfield><subfield code="a">DE-573</subfield><subfield code="a">DE-M347</subfield><subfield code="a">DE-92</subfield><subfield code="a">DE-1051</subfield><subfield code="a">DE-898</subfield><subfield code="a">DE-859</subfield><subfield code="a">DE-860</subfield><subfield code="a">DE-1049</subfield><subfield code="a">DE-861</subfield><subfield code="a">DE-863</subfield><subfield code="a">DE-862</subfield><subfield code="a">DE-Re13</subfield><subfield code="a">DE-Y3</subfield><subfield code="a">DE-255</subfield><subfield code="a">DE-Y7</subfield><subfield code="a">DE-Y2</subfield><subfield code="a">DE-70</subfield><subfield code="a">DE-2174</subfield><subfield code="a">DE-127</subfield><subfield code="a">DE-22</subfield><subfield code="a">DE-155</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-384</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-706</subfield><subfield code="a">DE-824</subfield><subfield code="a">DE-945</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-739</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Tulum, Öner</subfield><subfield code="d">ca. 20./21. Jh.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1279010541</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">From financialisation to innovation in UK big pharma</subfield><subfield code="b">AstraZeneca and GlaxoSmithKline</subfield><subfield code="c">Öner Tulum (The Academic-Industry Research Network), Antonio Andreoni (SOAS University of London), William Lazonick (The Academic-Industry Research Network)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, United Kingdom</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (104 Seiten)</subfield><subfield code="b">Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Cambridge elements. Elements in reinventing capitalism</subfield></datafield><datafield tag="653" ind1=" " ind2="2"><subfield code="a">AstraZeneca (Firm) / Finance</subfield></datafield><datafield tag="653" ind1=" " ind2="2"><subfield code="a">GlaxoSmithKline / Finance</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry / Finance / Great Britain</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Biotechnology industry / Finance / Great Britain</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Andreoni, Antonio</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1019224118</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lazonick, William</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)17006090X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Paperback</subfield><subfield code="z">978-1-009-27816-4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1017/9781009278140</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://directory.doabooks.org/handle/20.500.12854/142969</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CBO</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CUOA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-94-OAB</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034027060</subfield></datafield></record></collection>
id	DE-604.BV048652297
illustrated	Not Illustrated
indexdate	2025-01-24T23:01:40Z
institution	BVB
isbn	9781009278140
language	English
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-034027060
oclc_num	1362877374
open_access_boolean	1
owner	DE-12 DE-210 DE-521 DE-1102 DE-1046 DE-1028 DE-1050 DE-573 DE-M347 DE-92 DE-1051 DE-898 DE-BY-UBR DE-859 DE-860 DE-1049 DE-861 DE-863 DE-BY-FWS DE-862 DE-BY-FWS DE-Re13 DE-BY-UBR DE-Y3 DE-255 DE-Y7 DE-Y2 DE-70 DE-2174 DE-127 DE-22 DE-BY-UBG DE-155 DE-BY-UBR DE-91 DE-BY-TUM DE-384 DE-473 DE-BY-UBG DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-703 DE-20 DE-706 DE-824 DE-945 DE-29 DE-739
owner_facet	DE-12 DE-210 DE-521 DE-1102 DE-1046 DE-1028 DE-1050 DE-573 DE-M347 DE-92 DE-1051 DE-898 DE-BY-UBR DE-859 DE-860 DE-1049 DE-861 DE-863 DE-BY-FWS DE-862 DE-BY-FWS DE-Re13 DE-BY-UBR DE-Y3 DE-255 DE-Y7 DE-Y2 DE-70 DE-2174 DE-127 DE-22 DE-BY-UBG DE-155 DE-BY-UBR DE-91 DE-BY-TUM DE-384 DE-473 DE-BY-UBG DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-703 DE-20 DE-706 DE-824 DE-945 DE-29 DE-739
physical	1 Online-Ressource (104 Seiten) Diagramme
psigel	ZDB-20-CBO ZDB-20-CUOA ZDB-94-OAB
publishDate	2022
publishDateSearch	2022
publishDateSort	2022
publisher	Cambridge University Press
record_format	marc
series2	Cambridge elements. Elements in reinventing capitalism
spellingShingle	Tulum, Öner ca. 20./21. Jh Andreoni, Antonio Lazonick, William From financialisation to innovation in UK big pharma AstraZeneca and GlaxoSmithKline
title	From financialisation to innovation in UK big pharma AstraZeneca and GlaxoSmithKline
title_auth	From financialisation to innovation in UK big pharma AstraZeneca and GlaxoSmithKline
title_exact_search	From financialisation to innovation in UK big pharma AstraZeneca and GlaxoSmithKline
title_full	From financialisation to innovation in UK big pharma AstraZeneca and GlaxoSmithKline Öner Tulum (The Academic-Industry Research Network), Antonio Andreoni (SOAS University of London), William Lazonick (The Academic-Industry Research Network)
title_fullStr	From financialisation to innovation in UK big pharma AstraZeneca and GlaxoSmithKline Öner Tulum (The Academic-Industry Research Network), Antonio Andreoni (SOAS University of London), William Lazonick (The Academic-Industry Research Network)
title_full_unstemmed	From financialisation to innovation in UK big pharma AstraZeneca and GlaxoSmithKline Öner Tulum (The Academic-Industry Research Network), Antonio Andreoni (SOAS University of London), William Lazonick (The Academic-Industry Research Network)
title_short	From financialisation to innovation in UK big pharma
title_sort	from financialisation to innovation in uk big pharma astrazeneca and glaxosmithkline
title_sub	AstraZeneca and GlaxoSmithKline
url	https://doi.org/10.1017/9781009278140 https://directory.doabooks.org/handle/20.500.12854/142969
work_keys_str_mv	AT tulumoner fromfinancialisationtoinnovationinukbigpharmaastrazenecaandglaxosmithkline AT andreoniantonio fromfinancialisationtoinnovationinukbigpharmaastrazenecaandglaxosmithkline AT lazonickwilliam fromfinancialisationtoinnovationinukbigpharmaastrazenecaandglaxosmithkline

Availability

Order (Login required)

Read online (freely available)
Order paper/chapter scan